Keywords
Last Name
Institution

THOMAS R CATE

TitleProfessor Emeritus
InstitutionBaylor College of Medicine
DepartmentDepartment of Medicine
AddressOne Baylor Plaza-BCM280-Rm 205A
BCM-MD Anderson Hall
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor Emeritus
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Atmar RL, Keitel WA, Quarles JM, Cate TR, Patel SM, Nino D, Wells J, Arden N, Guo K, Hill H, Couch RB. Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. Vaccine. 2011 Oct 19; 29(45):8066-72. PMID: 21864622; PMCID: PMC3196602.
    2. Frenck RW, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB, Cate TR, Edwards KM, Hill H, Wolff M, Leduc T, Tornieporth N. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine. 2011 Aug 5; 29(34):5666-74. PMID: 21699951; PMCID: PMC3150501.
    3. Cate TR, Rayford Y, Niño D, Winokur P, Brady R, Belshe R, Chen W, Atmar RL, Couch RB. A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects. Vaccine. 2010 Feb 25; 28(9):2076-9. PMID: 20044052; PMCID: PMC2853016.
    4. Patel SM, Atmar RL, El Sahly HM, Cate TR, Keitel WA. A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route. Vaccine. 2010 Apr 9; 28(17):3025-9. PMID: 19931380; PMCID: PMC2913582.
    5. Couch RB, Atmar RL, Cate TR, Quarles JM, Keitel WA, Arden NH, Wells J, Niño D, Wyde PR. Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans. Vaccine. 2009 Aug 27; 27(39):5344-8. PMID: 19607949; PMCID: PMC2778204.
    6. El Sahly HM, Atmar RL, Patel SM, Wells JM, Cate T, Ho M, Guo K, Pasetti MF, Lewis DE, Sztein MB, Keitel WA. Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans. Vaccine. 2009 Aug 6; 27(36):4905-11. PMID: 19567246; PMCID: PMC2726995.
    7. Keitel WA, Atmar RL, Nino D, Cate TR, Couch RB. Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants. J Infect Dis. 2008 Oct 1; 198(7):1016-8. PMID: 18729777.
      View in: PubMed
    8. Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, Edwards KM. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 2008 Jul 29; 26(32):4057-61. PMID: 18602726; PMCID: PMC2605420.
    9. Couch RB, Winokur P, Brady R, Belshe R, Chen WH, Cate TR, Sigurdardottir B, Hoeper A, Graham IL, Edelman R, He F, Nino D, Capellan J, Ruben FL. Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine. 2007 Nov 1; 25(44):7656-63. PMID: 17913310; PMCID: PMC2243220.
    10. Atmar RL, Keitel WA, Cate TR, Munoz FM, Ruben F, Couch RB. A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults. Vaccine. 2007 Jul 20; 25(29):5367-73. PMID: 17559990; PMCID: PMC2063441.
    11. Atmar RL, Keitel WA, Patel SM, Katz JM, She D, El Sahly H, Pompey J, Cate TR, Couch RB. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis. 2006 Nov 1; 43(9):1135-42. PMID: 17029131.
      View in: PubMed
    12. Keitel WA, Atmar RL, Cate TR, Petersen NJ, Greenberg SB, Ruben F, Couch RB. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch Intern Med. 2006 May 22; 166(10):1121-7. PMID: 16717175.
      View in: PubMed
    13. Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. J Infect Dis. 2006 May 1; 193(9):1223-8. PMID: 16586358.
      View in: PubMed
    14. McCool TL, Cate TR, Tuomanen EI, Adrian P, Mitchell TJ, Weiser JN. Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun. 2003 Oct; 71(10):5724-32. PMID: 14500493; PMCID: PMC201056.
    15. McCool TL, Cate TR, Moy G, Weiser JN. The immune response to pneumococcal proteins during experimental human carriage. J Exp Med. 2002 Feb 4; 195(3):359-65. PMID: 11828011; PMCID: PMC2193593.
    16. Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. J Infect Dis. 2001 Jan 15; 183(2):329-332. PMID: 11110645.
      View in: PubMed
    17. Frangogiannis NG, Cate TR. Endocarditis and Ureaplasma urealyticum osteomyelitis in a hypogammaglobulinemic patient. A case report and review of the literature. J Infect. 1998 Sep; 37(2):181-4. PMID: 9821094.
      View in: PubMed
    18. Cate TR. Impact of influenza and other community-acquired viruses. Semin Respir Infect. 1998 Mar; 13(1):17-23. PMID: 9543472.
      View in: PubMed
    19. White AC, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997 Aug; 25(2):230-9. PMID: 9332517.
      View in: PubMed
    20. Couch RB, Keitel WA, Cate TR. Improvement of inactivated influenza virus vaccines. J Infect Dis. 1997 Aug; 176 Suppl 1:S38-44. PMID: 9240693.
      View in: PubMed
    21. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine. 1997 Jul; 15(10):1114-22. PMID: 9269055.
      View in: PubMed
    22. Mbawuike IN, Piedra PA, Cate TR, Couch RB. Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine. J Med Virol. 1996 Oct; 50(2):105-11. PMID: 8915874.
      View in: PubMed
    23. Frangogiannis NG, Boridy I, Mazhar M, Mathews R, Gangopadhyay S, Cate T. Cyclophosphamide in the treatment of toxic epidermal necrolysis. South Med J. 1996 Oct; 89(10):1001-3. PMID: 8865797.
      View in: PubMed
    24. Keitel WA, Cate TR, Atmar RL, Turner CS, Nino D, Dukes CM, Six HR, Couch RB. Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly. Clin Diagn Lab Immunol. 1996 Sep; 3(5):507-10. PMID: 8877126; PMCID: PMC170397.
    25. Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection. Experience in an urban public hospital. Arch Intern Med. 1996 Aug 12-26; 156(15):1710-6. PMID: 8694670.
      View in: PubMed
    26. Atmar RL, Keitel WA, Cate TR, Quarles JM, Couch RB. Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults. J Infect Dis. 1995 Jul; 172(1):253-7. PMID: 7797925.
      View in: PubMed
    27. Mbawuike IN, Dillion SB, Demuth SG, Jones CS, Cate TR, Couch RB. Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein. Vaccine. 1994 Nov; 12(14):1340-8. PMID: 7856302.
      View in: PubMed
    28. Keitel WA, Couch RB, Cate TR, Hess KR, Baxter B, Quarles JM, Atmar RL, Six HR. High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults. J Clin Microbiol. 1994 Oct; 32(10):2468-73. PMID: 7814484; PMCID: PMC264085.
    29. Genta RM, Bleyzer I, Cate TR, Tandon AK, Yoffe B. In situ hybridization and immunohistochemical analysis of cytomegalovirus-associated ileal perforation. Gastroenterology. 1993 Jun; 104(6):1822-7. PMID: 8388840.
      View in: PubMed
    30. Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. J Infect Dis. 1993 Feb; 167(2):305-11. PMID: 8421165.
      View in: PubMed
    31. Dowell ME, Ross PG, Musher DM, Cate TR, Baughn RE. Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus. Am J Med. 1992 Nov; 93(5):481-8. PMID: 1442850.
      View in: PubMed
    32. Rodriguez-Barradas MC, Musher DM, Lahart C, Lacke C, Groover J, Watson D, Baughn R, Cate T, Crofoot G. Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infected subjects with 23-valent pneumococcal vaccine. J Infect Dis. 1992 Mar; 165(3):553-6. PMID: 1347058.
      View in: PubMed
    33. Mbawuike IN, Six HR, Cate TR, Couch RB. Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes. J Virol. 1990 Mar; 64(3):1370-4. PMID: 2304146; PMCID: PMC249259.
    34. Keitel WA, Couch RB, Cate TR, Six HR, Baxter BD. Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge. J Infect Dis. 1990 Jan; 161(1):22-6. PMID: 2153185.
      View in: PubMed
    35. Cate TR. Prevention of severe lower respiratory tract infections. Semin Respir Infect. 1989 Dec; 4(4):243-4. PMID: 2626599.
      View in: PubMed
    36. Keitel WA, Cate TR, Couch RB. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol. 1988 Feb; 127(2):353-64. PMID: 3337087.
      View in: PubMed
    37. Murphy BR, Rennels MB, Douglas RG, Betts RF, Couch RB, Cate TR, Chanock RM, Kendal AP, Maassab HF, Suwanagool S, Sotman SB, Cisneros LA, Anthony WC, Nalin DR, Levine MM. Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers. Infect Immun. 1980 Aug; 29(2):348-55. PMID: 7216417; PMCID: PMC551124.
    38. Murphy BR, Markoff LJ, Chanock RM, Spring SB, Maassab HF, Kendal AP, Cox NJ, Levine MM, Douglas RG, Betts RF, Couch RB, Cate TR. Genetic approaches to attenuation of influenza A viruses for man. Philos Trans R Soc Lond B Biol Sci. 1980 Feb 25; 288(1029):401-15. PMID: 6103558.
      View in: PubMed
    39. Murphy BR, Chanock RM, Levine MM, van Blerk GA, Berquist EJ, Douglas RG, Betts RF, Couch RB, Cate TR. Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers. Infect Immun. 1979 Feb; 23(2):249-52. PMID: 422239; PMCID: PMC414156.
    40. Murphy BR, Markoff LJ, Hosier NT, Rusten HM, Chanock RM, Kendal AP, Douglas RG, Betts RF, Cate TR, Couch RB, Levine MM, Waterman DH, Holley HP. Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers. Infect Immun. 1978 Jun; 20(3):671-7. PMID: 669819; PMCID: PMC421911.
    CATE's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _